Hamilton Thorne Past Earnings Performance
Past criteria checks 0/6
Hamilton Thorne's earnings have been declining at an average annual rate of -15.2%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 17.2% per year.
Key information
-15.2%
Earnings growth rate
-20.0%
EPS growth rate
| Medical Equipment Industry Growth | -19.2% |
| Revenue growth rate | 17.2% |
| Return on equity | -0.9% |
| Net Margin | -0.9% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Reasonably Well
Aug 15
At CA$1.40, Is Hamilton Thorne Ltd. (CVE:HTL) Worth Looking At Closely?
May 25Is Hamilton Thorne (CVE:HTL) Using Too Much Debt?
Mar 30These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Safely
Oct 05Should You Think About Buying Hamilton Thorne Ltd. (CVE:HTL) Now?
Jun 10Hamilton Thorne (CVE:HTL) Will Be Hoping To Turn Its Returns On Capital Around
May 15Is Hamilton Thorne (CVE:HTL) A Risky Investment?
Apr 12Estimating The Fair Value Of Hamilton Thorne Ltd. (CVE:HTL)
Mar 15When Should You Buy Hamilton Thorne Ltd. (CVE:HTL)?
Mar 01Has Hamilton Thorne (CVE:HTL) Got What It Takes To Become A Multi-Bagger?
Feb 01Announcing: Hamilton Thorne (CVE:HTL) Stock Soared An Exciting 590% In The Last Five Years
Jan 19Are Insiders Selling Hamilton Thorne Ltd. (CVE:HTL) Stock?
Jan 06What Did Hamilton Thorne's (CVE:HTL) CEO Take Home Last Year?
Dec 24
We Think Hamilton Thorne (CVE:HTL) Can Stay On Top Of Its Debt
Dec 12Is It Time To Consider Buying Hamilton Thorne Ltd. (CVE:HTL)?
Nov 30A Look At The Fair Value Of Hamilton Thorne Ltd. (CVE:HTL)
Nov 17Here's Why Hamilton Thorne (CVE:HTL) Can Manage Its Debt Responsibly
Aug 24Is Now An Opportune Moment To Examine Hamilton Thorne Ltd. (CVE:HTL)?
Aug 10At CA$1.43, Is Hamilton Thorne Ltd. (CVE:HTL) Worth Looking At Closely?
Aug 10A Look At The Intrinsic Value Of Hamilton Thorne Ltd. (CVE:HTL)
Jul 27Revenue & Expenses BreakdownBeta
How Hamilton Thorne makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 67 | -1 | 29 | 4 |
| 30 Sep 23 | 65 | 0 | 28 | 4 |
| 30 Jun 23 | 63 | 1 | 26 | 4 |
| 31 Mar 23 | 61 | 1 | 24 | 4 |
| 31 Dec 22 | 58 | 2 | 23 | 4 |
| 30 Sep 22 | 57 | 2 | 22 | 4 |
| 30 Jun 22 | 57 | 2 | 21 | 4 |
| 31 Mar 22 | 55 | 2 | 20 | 4 |
| 31 Dec 21 | 52 | 2 | 19 | 3 |
| 30 Sep 21 | 49 | 3 | 17 | 3 |
| 30 Jun 21 | 46 | 3 | 16 | 3 |
| 31 Mar 21 | 41 | 2 | 15 | 3 |
| 31 Dec 20 | 40 | 1 | 15 | 3 |
| 30 Sep 20 | 38 | 1 | 15 | 3 |
| 30 Jun 20 | 37 | 1 | 15 | 3 |
| 31 Mar 20 | 38 | 2 | 14 | 3 |
| 31 Dec 19 | 35 | 1 | 13 | 2 |
| 30 Sep 19 | 33 | 3 | 12 | 2 |
| 30 Jun 19 | 31 | 2 | 11 | 2 |
| 31 Mar 19 | 30 | 2 | 11 | 2 |
| 31 Dec 18 | 29 | 3 | 11 | 2 |
| 30 Sep 18 | 28 | 5 | 11 | 2 |
| 30 Jun 18 | 28 | 6 | 10 | 2 |
| 31 Mar 18 | 26 | 6 | 10 | 2 |
| 31 Dec 17 | 22 | 6 | 9 | 2 |
| 30 Sep 17 | 19 | 2 | 7 | 1 |
| 30 Jun 17 | 15 | 1 | 6 | 1 |
| 31 Mar 17 | 12 | 1 | 5 | 1 |
| 31 Dec 16 | 11 | 1 | 5 | 1 |
| 30 Sep 16 | 9 | 1 | 4 | 1 |
| 30 Jun 16 | 9 | 1 | 4 | 1 |
| 31 Mar 16 | 9 | 1 | 4 | 1 |
| 31 Dec 15 | 9 | 1 | 4 | 1 |
| 30 Sep 15 | 9 | 1 | 4 | 1 |
| 30 Jun 15 | 9 | 1 | 4 | 1 |
| 31 Mar 15 | 9 | 1 | 4 | 1 |
| 31 Dec 14 | 9 | 1 | 4 | 1 |
| 30 Sep 14 | 8 | 1 | 4 | 1 |
| 30 Jun 14 | 8 | 1 | 4 | 1 |
| 31 Mar 14 | 8 | 0 | 3 | 1 |
| 31 Dec 13 | 7 | 0 | 3 | 1 |
| 30 Sep 13 | 7 | 0 | 3 | 1 |
| 30 Jun 13 | 7 | 0 | 4 | 1 |
Quality Earnings: HTL is currently unprofitable.
Growing Profit Margin: HTL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HTL is unprofitable, and losses have increased over the past 5 years at a rate of 15.2% per year.
Accelerating Growth: Unable to compare HTL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HTL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).
Return on Equity
High ROE: HTL has a negative Return on Equity (-0.94%), as it is currently unprofitable.